Source: AMFI. NAVs update every business day; fund size as of 12 Nov 2026.
Over 5 years the Direct plan trailed its benchmark by 0.05% a year.
| 1Y | 3Y | 5Y | Since launch | |
|---|---|---|---|---|
| This fund · Direct | +16.63% | +20.62% | +15.52% | +15.54% |
| This fund · Regular | +14.57% | +18.41% | +13.26% | +13.28% |
| NIFTY Healthcare TRI | +17.62% | +21.29% | +15.57% | +15.61% |
Green: ahead of the benchmark, red: behind. 3 years and more are yearly (CAGR). Source: AMFI scheme performance, NAVs of 12 Nov 2026. Past performance is not a guide to future returns.
For information only; not a recommendation. Mutual fund investments are subject to market risks; read all scheme-related documents carefully.
From ITI Mutual Fund's monthly portfolio disclosure: asset allocation and every holding by category, with its share of the fund's net assets.
From the scheme details ITI Mutual Fund files with AMFI.
An open ended Equity scheme investing in Pharma and Healthcare
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
4 variants of this fund with latest NAV and returns.
| Plan · Option | NAV | 1Y | 3Y |
|---|---|---|---|
Direct · Growth | ₹20.5606 | +16.8% | +20.5% |
Direct · IDCW Payout & reinvestment | ₹20.5583 | +16.8% | +20.5% |
Regular · Growth | ₹18.6207 | +14.7% | +18.3% |
Regular · IDCW Payout & reinvestment | ₹18.6207 | +14.7% | +18.3% |
Direct plans have a lower expense ratio as no distributor commission is paid; Regular plans include ongoing support from a distributor. Check the scheme information document for objectives, risks, exit loads and costs before investing.
ITI Mutual Fund
Aditya Birla Sun Life Mutual Fund
Aditya Birla Sun Life Mutual Fund
Aditya Birla Sun Life Mutual Fund
Aditya Birla Sun Life Mutual Fund
Bajaj Finserv Mutual Fund